Advertisement

Topics

OncoGenex Technologies Inc. Company Profile

00:32 EDT 25th September 2017 | BioPortfolio

OncoGenex Technologies Inc. (OncoGenex) is a clinical-stage biotechnology company dedicated to improving survival and quality of life of cancer patients by developing targeted therapeutics for treatment-resistant and metastatic cancer. The company's lead drug candidate, OGX-011, has commenced Phase 2 studies in prostate cancer (2), NSCLC and breast cancer. OGX-427 is in preclinical development and is expected to enter clinical investigation early in 2007

Location

Suite 400 – 1001 West Broadway
Vancouver
British Columbia
V6H 4B1
Canada

Contact

Phone: (604) 736-3678
Fax: (604) 736-3687


News Articles [441 Associated News Articles listed on BioPortfolio]

OncoGenex to Report First Quarter 2017 Financial Results on May 15, 2017

BOTHELL, Wash. and VANCOUVER, British Columbia, May 9, 2017 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that it will report its first quarter 2017 financial res...

Biotech-Roundup: Albireo, OncoGenex, Ritter, Palatin, Paion

Erneute Kursgewinne mit Ansage: Albireo Pharma (WKN: A2DF99) und OncoGenex (WKN: A0Q8G8) können in dieser Woche ihre Anleger begeistern. Bei Paion (WKN: A0B65S) ist die Luft wie erwartet erstmal ra.....

OncoGenex Reports Financial Results For First Quarter 2017

  Life Sciences Jobs   ...

Achieve Life Science Announces Closing Of Merger With OncoGenex

  Life Sciences Jobs   ...

Achieve Life Science And OncoGenex Announce Form S-4 Registration Statement Declared Effective By

  Life Sciences Jobs   ...

Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Form S-4 Registration Statement ...

The special meeting of the OGXI stockholders will be held on August 1, 2017, at 9 a.m. PTat 1191 Second Avenue, Floor 10, Read more...

XETR DELETION OF INSTRUMENTS FROM XETRA - 03.08.2017

The following instrument on XETRA do have their last trading day on 24.07.2017 Die folgenden Instrument in XETRA haben ihren letzten Handelstag am 24.07.2017 ISIN Name US68230A1060 ONCOGENEX PHARMA...

Albireo Pharma: Achtung Mergeralarm! Achtung Merger Euphorie?

Stand: Rostock, den 11.08.2017 / 13.30 Uhr Achtung Mergeralarm! Achtung Merger Euphorie? So oder so ähnlich schallte es durch wahrscheinlich etliche Börsenforen, als OncoGenex Pharmaceuticals Inc. ....

PubMed Articles [411 Associated PubMed Articles listed on BioPortfolio]

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [308 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1223 Associated Companies listed on BioPortfolio]

OncoGenex Technologies Inc.

OncoGenex Technologies Inc. (OncoGenex) is a clinical-stage biotechnology company dedicated to improving survival and quality of life of cancer patients by developing targeted therapeutics for treatme...

Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc.

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex...

OncoGenex Pharmaceuticals, Inc.

Teva Pharmaceutical Industries Ltd.

When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

More Information about "OncoGenex Technologies Inc." on BioPortfolio

We have published hundreds of OncoGenex Technologies Inc. news stories on BioPortfolio along with dozens of OncoGenex Technologies Inc. Clinical Trials and PubMed Articles about OncoGenex Technologies Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OncoGenex Technologies Inc. Companies in our database. You can also find out about relevant OncoGenex Technologies Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record